Parker Waichman LLP Files Plavix Wrongful Death Lawsuit on Behalf of the Estate of a Mississippi Woman who Suffered Fatal Gastrointestinal Hemorrhage While Taking Plavix

Share Article

National law firm of Parker Waichman LLP files Plavix wrongful death lawsuit on behalf of the estate of a Mississippi woman who suffered a fatal gastrointestinal hemorrhage while taking Plavix. The complaint is one of numerous Plavix lawsuits filed by Parker Waichman LLP on behalf of victims allegedly suffering bleeding side effects from Plavix.

Parker Waichman LLP, a national law firm representing people injured by defective drugs, has filed a wrongful death lawsuit on behalf of the estate of a Mississippi woman who suffered a fatal gastrointestinal hemorrhage while taking Plavix. The Plavix wrongful death lawsuit was filed in the Supreme Court of the State of New York, County of New York, on February 29, 2012 (Index No. 150388/2012). Bristol -Myers Squibb Company and Sanofi-Aventis U.S., L.L.C. are named as Defendants in the complaints.

According to the lawsuit, which was filed on behalf of James Traywick for the estate of Robbie Mae Traywick, the Plaintiff-Decedent was prescribed Plavix in February 2004, and continued using the medication until March 2009. On or about March 11, 2009, Ms. Traywick suffered from a gastrointestinal hemorrhage and subsequently died.

Plavix, a blood thinner known generically as clopidogrel, was first approved by the U.S. Food and Drug Administration (FDA) in 1997 for the prevention of heart attack and stroke. The Traywick lawsuit alleges the Defendants falsely touted the drug as being more effective and safer in reducing the risk of ischemic events compared to a less expensive daily aspirin regimen.

The Traywick lawsuit alleges that the Plaintiff-Decedent’s use of Plavix caused severe personal injuries which are permanent and lasting in nature, and physical pain and mental anguish, including diminished enjoyment of life. Among other things, the complaint alleges that Bristol-Myers Squibb and Sanofi-Aventis negligently and/or fraudulently represented to the medical and healthcare community, the FDA, the Plaintiff-Decedent and the public in general, that Plavix had been tested and was found to be safe and/or effective for its indicated use. The lawsuit further charges that the Defendants concealed their knowledge of Plavix defects from the Plaintiff-Decedent, the FDA, the public in general and/or the medical community specifically.

The lawsuit charges Bristol-Myers Squibb and Sanofi-Aventis with Negligence; Strict Products Liability, including Defective Design, Manufacturing Defect, and Failure to Warn; Breach of Express and Implied Warranties; Fraudulent Misrepresentation; Fraudulent Concealment; Negligent Misrepresentation; Fraud and Deceit; Consumer Fraud under New York State's General Business Law, and Wrongful Death.

Parker Waichman LLP is currently representing numerous plaintiffs in lawsuits alleging Plavix caused serious, life-threatening side effects, including gastrointestinal bleeding, cerebral hemorrhaging, and death. According to the firm, on the same day the Traywick complaint was filed, attorneys with Parker Waichman LLP filed an additional 17 lawsuits in the Supreme Court of the State of New York, County of New York on behalf of people who allegedly suffered severe injuries due to their use of Plavix.

Parker Waichman LLP continues to offer free legal consultations to victims of Plavix side effects. If you or a loved one experienced serious, life-threatening or fatal internal bleeding, heart attacks, strokes, or a blood disorder, and you believe Plavix is to blame, please contact their office by visiting the firm's Plavix side effects page at Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

For more information regarding Plavix side effects lawsuits and Parker Waichman LLP, please visit: or call 1-800-LAW-INFO (1-800-529-4636).

Parker Waichman LLP
Herbert Waichman, Partner
(800) LAW-INFO
(800) 529-4636

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Herbert Waichman